ASSET PURCHASE AGREEMENT by and among BIOVIE INC., AS BUYER, NEURMEDIX, INC., AS SELLER, and ACUITAS GROUP HOLDINGS, LLC, AS GUARANTOR Dated as of April 27, 2021 ARTICLE I SALE AND PURCHASE OF ASSETS; CLOSINGAsset Purchase Agreement • April 27th, 2021 • Biovie Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 27th, 2021 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 27, 2021, by and among BioVie Inc., a Nevada corporation (“Buyer”), NeurMedix, Inc., a Delaware corporation (“Seller”), and Acuitas Group Holdings, LLC, a California limited liability company (“Guarantor”), solely for purposes of Section 10.16. Buyer, Seller and the Guarantor may be referred to herein, collectively, as the “Parties” and, individually, as a “Party.”
ASSET PURCHASE AGREEMENT by and among BioVie Inc., as Buyer, NeurMedix, Inc., as Seller, and Acuitas Group Holdings, LLC, as Guarantor Dated as of April 27, 2021Asset Purchase Agreement • April 27th, 2021 • Peizer Terren S • Pharmaceutical preparations • Delaware
Contract Type FiledApril 27th, 2021 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 27, 2021, by and among BioVie Inc., a Nevada corporation (“Buyer”), NeurMedix, Inc., a Delaware corporation (“Seller”), and Acuitas Group Holdings, LLC, a California limited liability company (“Guarantor”), solely for purposes of Section 10.16. Buyer, Seller and the Guarantor may be referred to herein, collectively, as the “Parties” and, individually, as a “Party.”